KR20230037295A - Form for wet dressing and wet dressing used the same that - Google Patents
Form for wet dressing and wet dressing used the same that Download PDFInfo
- Publication number
- KR20230037295A KR20230037295A KR1020210120454A KR20210120454A KR20230037295A KR 20230037295 A KR20230037295 A KR 20230037295A KR 1020210120454 A KR1020210120454 A KR 1020210120454A KR 20210120454 A KR20210120454 A KR 20210120454A KR 20230037295 A KR20230037295 A KR 20230037295A
- Authority
- KR
- South Korea
- Prior art keywords
- foam
- wet dressing
- water
- absorbent layer
- type wet
- Prior art date
Links
- 239000006261 foam material Substances 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 11
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 11
- 239000006260 foam Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims description 19
- 230000002745 absorbent Effects 0.000 claims description 18
- 239000002250 absorbent Substances 0.000 claims description 18
- 239000010410 layer Substances 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 claims description 10
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 9
- 210000000416 exudates and transudate Anatomy 0.000 claims description 9
- 229920002558 Curdlan Polymers 0.000 claims description 8
- 239000001879 Curdlan Substances 0.000 claims description 8
- 229940078035 curdlan Drugs 0.000 claims description 8
- 235000019316 curdlan Nutrition 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 4
- 230000032683 aging Effects 0.000 claims description 4
- 239000012790 adhesive layer Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 239000011241 protective layer Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 abstract description 4
- 229920005989 resin Polymers 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 206010052428 Wound Diseases 0.000 description 19
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229920005830 Polyurethane Foam Polymers 0.000 description 3
- 239000011496 polyurethane foam Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000588813 Alcaligenes faecalis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- -1 Demethyl sulfoxide Chemical class 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229940005347 alcaligenes faecalis Drugs 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
- A61F13/0286—Apparatus or processes for manufacturing adhesive dressings or bandages manufacturing of non adhesive dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/62—Compostable, hydrosoluble or hydrodegradable materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00217—Wound bandages not adhering to the wound
- A61F2013/00221—Wound bandages not adhering to the wound biodegradable, non-irritating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
- A61F2013/0074—Plasters means for wound humidity control with absorbing pads containing foams
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing & Machinery (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
본 발명은 폼타입 습윤드레싱용 폼재 제조방법 및 이 폼재가 사용된 폼타입 습윤드레싱에 관한 것으로서, 보다 상세하게는 수용성이며 생분해성을 가지는 폴리비닐알코올을 비롯하여 인체에 무해하고 친환경적인 소재를 사용하여 습윤드레싱용 폼재를 제조하는 새로운 방식의 폼타입 습윤드레싱용 폼재 제조방법 및 이 폼재가 사용된 폼타입 습윤드레싱에 관한 것이다.The present invention relates to a method for manufacturing a foam material for a foam-type wet dressing and a foam-type wet dressing using the foam material, and more particularly, to a water-soluble and biodegradable polyvinyl alcohol, which is harmless to the human body and is environmentally friendly. It relates to a new method of manufacturing a foam material for a wet dressing and a foam type wet dressing using the foam material.
피부 조직의 상처는 일반적으로 염증기 → 증식기 → 성숙기(새로운 조직 구성)의 과정을 거쳐 치유되며, 상처의 깊이에 따라 다르겠지만 표피층의 상처는 보통 공기 중에 노출되면 6~7일, 습윤 환경이 유지되면 4일 정도면 회복된다. 염증 반응은 지혈을 통해 출혈을 막고, 세균이나 이물질을 제거하여 상처 부위를 깨끗하게 하는 단계이며, 이후 증식 과정을 거치면서 상처 부위에 새로운 혈관이 생성되고 결손이 생긴 부위가 채워진다. 마지막으로 성숙기에 들어가면 염증세포들과 새로운 혈관의 생성은 사라지고, 콜라겐의 분해와 합성을 반복하며 흉터 부위가 최소화하고 상처를 완전히 회복한다. Skin tissue wounds are generally healed through the process of inflammatory phase → proliferative phase → maturation phase (new tissue formation). It may vary depending on the depth of the wound, but wounds in the epidermal layer usually heal within 6 to 7 days when exposed to air and when maintained in a moist environment. It recovers in about 4 days. The inflammatory response is a step in which bleeding is stopped through hemostasis and bacteria or foreign substances are removed to clean the wound. Afterwards, through a proliferative process, new blood vessels are created in the wound and the defect is filled. Finally, in the mature stage, the formation of inflammatory cells and new blood vessels disappears, and the decomposition and synthesis of collagen are repeated, minimizing the scar area and completely recovering the wound.
상처에 대한 응급처치를 한 후 흉터를 최소화하면서 빠른 시간 안에 상처를 치료하기 위해 상처 부위를 드레싱한다. 드레싱 방법에는 거즈를 사용하여 상처 부위를 덮는 전통적 방법인 거즈드레싱과 상처 부위를 밀폐하여 습윤환경을 유지하는 습윤드레싱이 있다.After administering first aid to the wound, dress the wound to heal the wound quickly while minimizing scarring. Dressing methods include gauze dressing, which is a traditional method of covering the wound using gauze, and wet dressing, which seals the wound to maintain a moist environment.
습윤드레싱 방법은 외부환경으로부터 상처부위를 차단하여 2차 감염을 예방하는 기능을 기본으로 하며, 아울러 상처에서 생긴 삼출물을 흡수하여 수분과 삼출물이 적절히 유지되는 습윤환경을 조성하여 상처표면이 건조해져 발생되는 딱지(scab)를 억제하고, 그로 인해 상처를 빠르게 치유할 수 있도록 한다. The wet dressing method is based on the function of preventing secondary infection by blocking the wound from the external environment, and also absorbs the exudate from the wound to create a moist environment in which moisture and exudate are properly maintained, resulting in the wound surface becoming dry. It inhibits the formation of scabs, thereby allowing wounds to heal quickly.
이러한 습윤드레싱은 하이드로콜로이드와 폼 타입으로 분류되는데, 폼타입 습윤드레싱은 하이드로콜로이드타입에 비해 삼출물의 흡수가 뛰어나기 때문에 삼출물이 많은 상처에 사용이 적합하다. 이러한 폼타입 습윤드레싱은 삼출물을 흡수하여 습윤환경을 유지하는 흡수층과, 흡수층을 커버하여 미생물의 투입을 방지하는 방수성 보호층과, 흡수층 저면에 형성된 점착층으로 이루어지는데, 대부분 흡수층은 폴리우레탄폼으로 이루어진다.These wet dressings are classified into hydrocolloid and foam types, and foam-type wet dressings are more suitable for use in wounds with a lot of exudate because they absorb exudates better than hydrocolloid types. This foam-type wet dressing consists of an absorbent layer that absorbs exudate and maintains a moist environment, a waterproof protective layer that covers the absorbent layer to prevent the introduction of microorganisms, and an adhesive layer formed on the bottom of the absorbent layer. Most of the absorbent layer is made of polyurethane foam. It is done.
한편, 폴리우레탄은 폴리올과 디이소시아네이트의 반응에 의해 생성되는 것으로서, 폴리올과 디이소시아네이트를 비롯하여 가교제, 촉매 등 다양한 화학약품이 사용된다. 폴리우레탄은 쉽게 분해되지 않으므로 환경오염도 유발시킨다. On the other hand, polyurethane is produced by the reaction of polyol and diisocyanate, and various chemicals such as polyol and diisocyanate as well as crosslinking agents and catalysts are used. Polyurethane does not decompose easily, so it causes environmental pollution.
본 발명은 상기와 같은 문제점에 착안하여 제안된 것으로서, 본 발명의 목적은 수용성이며 생분해성을 가지는 폴리비닐알코올을 비롯하여 인체에 무해하고 친환경적인 소재를 사용하여 폼타입 습윤드레싱용 폼재를 제조하는 새로운 방식의 폼타입 습윤드레싱용 폼재 제조방법 및 이러한 방법에 의해 제조되어 흡수성도 우수하고, 인체에 무해하며 환경친화적인 장점을 가지는 새로운 구성의 폼재가 사용된 폼타입 습윤드레싱을 제공하는 것이다.The present invention has been proposed in view of the above problems, and an object of the present invention is to manufacture a new foam material for foam-type wet dressing using materials harmless to the human body and eco-friendly, including polyvinyl alcohol having water-soluble and biodegradable properties. To provide a method of manufacturing a foam material for a form-type wet dressing and a form-type wet dressing using a foam material manufactured by this method and having excellent absorbency, harmless to the human body, and environmentally friendly foam material of a new configuration.
본 발명의 특징에 따르면, 폼타입 습윤드레싱의 흡수층으로 사용되는 폼재를 제조하는 방법으로서, (1) 물 100부피부에 폴리비닐알코올 5~25부피부를 용해시키고, 디메틸술폭사이드 10~15부피부와 커들란 2~10부피부를 투입하고 교반시켜서 원료혼합액을 만드는 과정; (2) 상기 (1)과정에서 만든 원료혼합액에 약산과 아니스알데하이드(Anisaldehyde)를 첨가하고 교반시켜서 원료혼합액을 페이스트상태로 만드는 과정; (3)상기 (2)과정에서 만든 페이스트상태의 원료혼합액에 수용성 기포형성제를 첨가하여 교반시키는 과정; (4)상기 (3)과정에서 수용성 기포형성제가 첨가된 페이스트상태의 원료혼합액을 필름형태로 성형하는 과정; (5)상기 (4)과정에서 성형된 필름을 수세하여 상기 수용성 기포형성제를 추출제거함으로써, 상기 필름을 오픈 셀(Open Cell)에 의한 3차원 망상구조를 가지지도록 폼화시키는 과정; (6) 상기 (5)과정에서 폼화된 필름을 건조시키는 과정; 및 (7) 상기 (6)과정에서 건조된 필름을 숙성시키는 과정;을 포함하는 것을 특징으로 하는 폼타입 습윤드레싱용 폼재 제조방법 및 이에 의해 제조된 폼재가 흡수층으로 사용된 폼타입 습윤드레싱이 제공된다. According to a feature of the present invention, as a method of manufacturing a foam material used as an absorbent layer of a foam-type wet dressing, (1) dissolving 5 to 25 parts by volume of polyvinyl alcohol in 100 parts by volume of water, and 10 to 15 parts by volume of dimethyl sulfoxide A process of preparing a mixture of raw materials by adding 2 to 10 volumes of skin and curdlan and stirring; (2) adding a weak acid and anisaldehyde to the raw material mixture prepared in step (1) and stirring to make the raw material mixture into a paste state; (3) adding a water-soluble foam-forming agent to the mixture of raw materials in a paste form prepared in the step (2) and stirring the mixture; (4) molding the mixture of raw materials in a paste state to which the water-soluble foam-forming agent is added in step (3) into a film form; (5) washing the film formed in step (4) with water to extract and remove the water-soluble foam-forming agent, thereby forming the film into a three-dimensional network structure by open cells; (6) drying the film formed in step (5); And (7) a process of aging the film dried in the step (6); a method for manufacturing a foam material for a foam-type wet dressing, characterized in that it includes, and a foam-type wet dressing using the foam material produced thereby as an absorbent layer is provided do.
이상과 같은 구성의 본 발명은 수용성 수지로서 생분해성을 가지는 폴리비닐알코올과 더불어 디메틸술폭사이드, 커들란, 약산, 아니스알데하이드 등의 인체에 무해한 성분들을 사용하여 폼재를 제조하는 것이며, 이러한 본 발명에 의해 제조되는 폼재는 종래의 폴리우레탄폼에 비해 인체에 무해하고 생분해성도 가지므로환경친화적인 장점을 가진다. 또한, 오픈셀에 의한 3차원 망상구조를 가져서 흡수성이 우수하므로 본 발명에 의한 폼재를 흡수층으로 사용하여 제조된 폼타입 습윤드레싱은 삼출물을 효과적으로 잘 흡수하여 상처가 좀 빠르게 치유될 수 있는 환경을 조성할 수 있는 고품질을 가진다. The present invention configured as described above is to manufacture a foam material using components harmless to the human body such as dimethyl sulfoxide, curdlan, weak acid, anisaldehyde, and the like along with polyvinyl alcohol having biodegradability as a water-soluble resin. Compared to the conventional polyurethane foam, the foam material manufactured by has the advantage of being environmentally friendly because it is harmless to the human body and has biodegradability. In addition, since it has a three-dimensional network structure by open cells and has excellent absorbency, the foam-type wet dressing prepared using the foam material according to the present invention as an absorbent layer absorbs exudate effectively and creates an environment in which wounds can heal more quickly It has the highest quality possible.
도 1은 본 발명에 따른 폼재를 사용한 폼타입 습윤드레싱의 단면도
1 is a cross-sectional view of a foam-type wet dressing using a foam material according to the present invention
이하에서는 본 발명을 좀 더 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 폼타입 습윤드레싱에서 상처에서 발생되는 삼출물을 흡수하는 흡수층으로 사용되는 폼재의 제조방법에 관한 것으로서, 다음과 같은 방법으로 제조된다.The present invention relates to a method for manufacturing a foam material used as an absorbent layer for absorbing exudate generated from a wound in a foam-type wet dressing, and is manufactured as follows.
1) 원료혼합과정1) Raw material mixing process
물 100부피부에 폴리비닐알코올 5~25부피부를 넣고 100℃ 정도로 가열하여 폴리비닐알코올을 용해시킨 다음, 5℃ 정도로 냉각시킨다. 이어서 디메틸술폭사이드 10~15부피부와 커들란 2~10부피부를 첨가하여 고르게 잘 교반시킨 다음, 90℃ 정도로 가열한 후 냉각시켜서 원료혼합액을 만든다.Add 5 to 25 parts by volume of polyvinyl alcohol to 100 parts by volume of water, heat to about 100 ° C to dissolve polyvinyl alcohol, and then cool to about 5 ° C. Subsequently, 10 to 15 parts by volume of dimethyl sulfoxide and 2 to 10 parts by volume of curdlan are added, stirred well, heated to about 90 ° C, and then cooled to prepare a raw material mixture.
폴리비닐알코올(Polyvinyl alcohol)은 수용성 수지로서 생분해성을 가지며, 인체에 무해하며, 화장품, 의료용 삽입보형물, 식품포장재 등 다양한 용도로 사용된다. Polyvinyl alcohol (Polyvinyl alcohol) is a water-soluble resin, has biodegradability, is harmless to the human body, and is used for various purposes such as cosmetics, medical implants, and food packaging materials.
디메틸술폭사이드(Demethyl sulfoxide)는 극성이 강하고 흡습성도 높은 유기용매로서, 인체에 대한 독성이 적고, 진통 및 항염증을 포함하는 다양한 약리적 활성을 가진다. Dimethyl sulfoxide (Demethyl sulfoxide) is an organic solvent with strong polarity and high hygroscopicity, has low toxicity to the human body, and has various pharmacological activities including analgesia and anti-inflammatory.
그리고 커들란(curdlan)은 β-1,3-글루칸이라고도 하는데, 알칼리게네스 파에칼리스(Alcaligenes faecalis)와 종양균(Agrobacterium)에서 생산된 다당류를 분리ㅇ정제하여 얻어지는 것으로서 글로코스의 고분자량 중합체이다. 흰색 또는 흰색과 유사한 색의 가루로서, 물 분산액을 80℃ 이상으로 가열하면 열불가역성의 겔을 형성한다. 이러한 커들란은 젤리, 면류, 케이크, 식육가공품 등에 증점제, 결착제, 피막형성제, 겔화제 등으로 사용된다. 이러한 커들란이 사용되면 제조되는 폼재의 인장강도가 증가되어 내구성 등의 기계적인 물성이 좋아진다. Curdlan, also called β-1,3-glucan, is a high molecular weight polymer of glucose obtained by isolating and purifying polysaccharides produced by Alcaligenes faecalis and Agrobacterium. . It is a white or white-like powder, which forms a thermo-irreversible gel when the water dispersion is heated above 80 °C. Such curdlan is used as a thickener, binder, film forming agent, gelling agent, etc. in jellies, noodles, cakes, and processed meat products. When such curdlan is used, the tensile strength of the foam material to be manufactured is increased, and mechanical properties such as durability are improved.
2) 원료혼합액의 점도조절과정2) Viscosity control process of raw material mixture
필름성형을 위해서는 원료혼합액의 점도를 높여 유동성을 저하시킬 필요가 있는데, 이를 위해 원료혼합액에 개미산 등의 약산을 첨가하여 원료혼합액의 pH를 pH5 정도의 약산성으로 조절하고, 아니스알데하이드 1~5부피부 첨가하여 고르게 잘 교반시킨다.For film formation, it is necessary to increase the viscosity of the mixture of raw materials to reduce fluidity. Add and stir evenly.
아니스알데하이드(Anisaldehyde)는 벤젠고리에 알데하이드기와 메톡시기가 치환된 유기화합물이다. 강한 방향을 내는 무색의 투명한 액체로서 인체에 무해하다. 베이커리 제품, 아이스크림에 착향료로 사용되며, 의약품이나 향수제조에도 사용된다. Anisaldehyde is an organic compound in which an aldehyde group and a methoxy group are substituted in a benzene ring. It is a colorless, transparent liquid with a strong aroma, harmless to the human body. It is used as a flavoring agent in bakery products and ice cream, and is also used in pharmaceuticals and perfumery.
이와 같이 처리하면 원료혼합액의 점도가 상승되어 원료혼합액이 페이스트상태가 된다.When treated in this way, the viscosity of the raw material mixture is increased and the raw material mixture is in a paste state.
3) 수용성 기포형성제 혼합과정3) Water-soluble foaming agent mixing process
페이스트상태의 원료혼합액에 전분, 텍스트린, 수용성 무기염 등의 수용성 기포형성제를 첨가하고 고르게 분산시킨다. Add water-soluble foam-forming agents such as starch, dextrin, and water-soluble inorganic salt to the mixture of raw materials in a paste state and disperse them evenly.
상기 수용성 기포형성제는 합성수지의 습식발포에 흔히 사용되는 성분들로서, 후술하는 바와 같이, 수세과정에서 물에 용해되어 제거됨에 따라 필름이 폼화된다. 폼재의 기공율, 기공크기 등에 따라 폼재의 흡수율이 달라지므로 폼재가 소요되는 수준의 흡수율을 가지도록 수성용 기포형성제의 첨가량의 조절하여 폼재의 기공율, 기공크기 등을 조절한다. The water-soluble foam-forming agent is a component commonly used in wet foaming of synthetic resin, and as will be described later, the film is foamed as it is dissolved in water and removed during the water washing process. Since the water absorption rate of the foam material varies depending on the porosity and pore size of the foam material, the porosity and pore size of the foam material are adjusted by adjusting the addition amount of the water-based foam former so that the foam material has the required water absorption rate.
4) 필름성형과정4) Film forming process
페이스트상태의 원료혼합액을 필름성형한다. 이형지 위에 페이스트상태의 원료혼합액을 나이프 코팅기(Knife coater) 또는 콤마 코팅기(Comma coater) 등의 필름제조장치를 이용하여 소정 두께로 코팅한 다음, 필름을 건조시킨다. The mixture of raw materials in a paste state is formed into a film. On the release paper, the mixture of raw materials in a paste state is coated to a predetermined thickness using a film manufacturing device such as a knife coater or a comma coater, and then the film is dried.
5) 폼화과정5) Formation process
건조시킨 필름을 수세하여 혼합액에 혼합된 기포형성제를 용해시켜서 제거한다. 이와 같이 기포형성제가 물에 용해되어 제거됨에 따라 필름에 오픈 셀(Open Cell)의 미세기공이 형성되어, 필름이 오픈 셀에 의한 3차원 망상구조를 가지게 된다.The dried film is washed with water to dissolve and remove the bubble forming agent mixed in the mixed solution. In this way, as the bubble forming agent is dissolved in water and removed, micropores of open cells are formed in the film, so that the film has a three-dimensional network structure by the open cells.
6) 건조과정6) Drying process
상기 과정에서 3차원 망상구조로 폼화된 필름을 100℃ 정도의 열풍건조기에서 건조시켜서, 필름의 기공에 잔존하는 수분을 제거한다. In the above process, the film formed into a three-dimensional network structure is dried in a hot air dryer at about 100° C. to remove moisture remaining in the pores of the film.
7) 숙성과정7) Aging process
건조시킨 필름을 이형지를 제거하고, 70~80℃에서 24시간 방치하여 숙성시킨다. 이러한 숙성과정을 통해 필름의 인장강도, 신장율과 같은 기계적 물성이 향상된다. Remove the release paper from the dried film and leave it for 24 hours at 70 ~ 80 ℃ to mature. Through this aging process, mechanical properties such as tensile strength and elongation of the film are improved.
8) 절단과정8) Cutting process
숙성시킨 필름을 원하는 크기로 절단하여 폼재를 완성한다.The aged film is cut to a desired size to complete the foam material.
이와 같이 완성된 제품, 즉, 폼재는 폼타입 습윤드레싱의 흡수층으로 사용된다. 도 1은 이와 같이 제조된 폼재를 흡수층으로 하는 폼타입 습윤드레싱(10)의 단면도로서, 도시된 바와 같이, 제조된 폼재, 즉, 흡수층(12)의 상면에 보호층(14)으로 폴리우레탄필름을 적층시키고, 저면에 점착제층(16)을 형성하여 폼타입 습윤드레싱을 만든다.The finished product, that is, the foam material, is used as an absorbent layer of a foam-type wet dressing. 1 is a cross-sectional view of a foam-type
이상과 같은 구성을 가지는 본 발명은 수용성 수지로서 생분해성을 가지는 폴리비닐알코올과 더불어 디메틸술폭사이드, 커들란, 약산, 아니스알데하이드 등의 인체에 무해한 성분들을 사용하여 폼재를 제조하는 것이며, 이러한 본 발명에 의해 제조되는 폼재는 종래의 폴리우레탄폼에 비해 인체에 무해하고 생분해성도 가지므로 환경친화적인 장점을 가진다. 또한, 오픈셀에 의한 3차원 망상구조를 가져서 흡수성이 우수하므로 본 발명에 의한 폼재를 흡수층으로 사용하여 제조된 폼타입 습윤드레싱은 삼출물을 효과적으로 잘 흡수하여 상처가 좀 빠르게 치유될 수 있는 환경을 조성할 수 있는 고품질을 가진다. The present invention having the configuration as described above is to manufacture a foam material using components harmless to the human body such as dimethyl sulfoxide, curdlan, weak acid, anisaldehyde, and the like, along with polyvinyl alcohol having biodegradability as a water-soluble resin. The foam material produced by has the advantage of being environmentally friendly because it is harmless to the human body and has biodegradability compared to conventional polyurethane foam. In addition, since it has a three-dimensional network structure by open cells and has excellent absorbency, the foam-type wet dressing prepared using the foam material according to the present invention as an absorbent layer absorbs exudate effectively and creates an environment in which wounds can heal more quickly It has the highest quality possible.
Claims (2)
(1) 물 100부피부에 폴리비닐알코올 5~25부피부를 용해시키고, 디메틸술폭사이드 10~15부피부와 커들란 2~10부피부를 투입하고 교반시켜서 원료혼합액을 만드는 과정;
(2) 상기 (1)과정에서 만든 원료혼합액에 약산과 아니스알데하이드(Anisaldehyde)를 첨가하고 교반시켜서 원료혼합액을 페이스트상태로 만드는 과정;
(3)상기 (2)과정에서 만든 페이스트상태의 원료혼합액에 수용성 기포형성제를 첨가하여 교반시키는 과정;
(4)상기 (3)과정에서 수용성 기포형성제가 첨가된 페이스트상태의 원료혼합액을 필름형태로 성형하는 과정;
(5)상기 (4)과정에서 성형된 필름을 수세하여 상기 수용성 기포형성제를 추출제거함으로써, 상기 필름을 오픈 셀(Open Cell)에 의한 3차원 망상구조를 가지지도록 폼화시키는 과정;
(6) 상기 (5)과정에서 폼화된 필름을 건조시키는 과정; 및
(7) 상기 (6)과정에서 건조된 필름을 숙성시키는 과정;을 포함하는 것을 특징으로 하는 폼타입 습윤드레싱용 폼재 제조방법.
As a method of manufacturing a foam material used as an absorbent layer of a foam-type wet dressing,
(1) Dissolving 5 to 25 parts by volume of polyvinyl alcohol in 100 parts by volume of water, adding 10 to 15 parts by volume of dimethyl sulfoxide and 2 to 10 parts by volume of curdlan, and stirring to prepare a raw material mixture;
(2) adding a weak acid and anisaldehyde to the raw material mixture prepared in step (1) and stirring to make the raw material mixture into a paste state;
(3) adding a water-soluble foam-forming agent to the mixture of raw materials in a paste form prepared in the above (2) process and stirring the mixture;
(4) forming a mixture of raw materials in a paste state to which a water-soluble bubble-forming agent is added in step (3) into a film form;
(5) washing the film formed in step (4) with water to extract and remove the water-soluble foam-forming agent, thereby forming the film into a three-dimensional network structure by open cells;
(6) drying the film formed in step (5); and
(7) a process of aging the film dried in the process (6); a method for manufacturing a foam material for a foam-type wet dressing, characterized in that it comprises.
상기 흡수층(12)은 청구항1에 기재된 방법으로 제조된 폼재로 이루어진 것을 특징으로 하는 폼타입 습윤드레싱.An absorbent layer 12 for absorbing exudate generated from a wound, a protective layer 14 laminated on the upper surface of the absorbent layer 12 to protect the absorbent layer 12, and an adhesive layer formed on the lower surface of the absorbent layer 12 ( In the foam type wet dressing comprising 16),
The absorbent layer 12 is a foam-type wet dressing, characterized in that made of a foam material manufactured by the method according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210120454A KR102534658B1 (en) | 2021-09-09 | 2021-09-09 | Form for wet dressing and wet dressing used the same that |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210120454A KR102534658B1 (en) | 2021-09-09 | 2021-09-09 | Form for wet dressing and wet dressing used the same that |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230037295A true KR20230037295A (en) | 2023-03-16 |
KR102534658B1 KR102534658B1 (en) | 2023-05-18 |
Family
ID=85985430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210120454A KR102534658B1 (en) | 2021-09-09 | 2021-09-09 | Form for wet dressing and wet dressing used the same that |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102534658B1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006068080A (en) * | 2004-08-31 | 2006-03-16 | Teijin Ltd | Bioabsorbable porous material having gradient structure |
KR200422370Y1 (en) | 2006-05-16 | 2006-07-25 | 강정열 | Wound Dressing |
KR20080112921A (en) * | 2007-06-21 | 2008-12-26 | 주식회사 원바이오젠 | A method for manufacturing hydrophilic wound dressing and the hydrophilic wound dressing |
KR20200059342A (en) * | 2018-11-20 | 2020-05-29 | 주식회사 티앤엘 | Antibacterial Nonwoven Dressing |
US20200324019A1 (en) * | 2019-04-11 | 2020-10-15 | Convatec Technologies Inc. | Superporous hydrogels, methods of making the same, and articles incorporating the same |
KR20210001661A (en) | 2019-06-28 | 2021-01-06 | 주식회사 티앤엘 | High Absorbent Foam Dressing With Silicone With Silicone foam |
KR20210098629A (en) | 2020-02-03 | 2021-08-11 | 주식회사 큐라젠 | Protruded polyurethane dressing foam using nitric oxide plasma and its manufacturing method |
-
2021
- 2021-09-09 KR KR1020210120454A patent/KR102534658B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006068080A (en) * | 2004-08-31 | 2006-03-16 | Teijin Ltd | Bioabsorbable porous material having gradient structure |
KR200422370Y1 (en) | 2006-05-16 | 2006-07-25 | 강정열 | Wound Dressing |
KR20080112921A (en) * | 2007-06-21 | 2008-12-26 | 주식회사 원바이오젠 | A method for manufacturing hydrophilic wound dressing and the hydrophilic wound dressing |
KR20200059342A (en) * | 2018-11-20 | 2020-05-29 | 주식회사 티앤엘 | Antibacterial Nonwoven Dressing |
US20200324019A1 (en) * | 2019-04-11 | 2020-10-15 | Convatec Technologies Inc. | Superporous hydrogels, methods of making the same, and articles incorporating the same |
KR20210001661A (en) | 2019-06-28 | 2021-01-06 | 주식회사 티앤엘 | High Absorbent Foam Dressing With Silicone With Silicone foam |
KR20210098629A (en) | 2020-02-03 | 2021-08-11 | 주식회사 큐라젠 | Protruded polyurethane dressing foam using nitric oxide plasma and its manufacturing method |
Also Published As
Publication number | Publication date |
---|---|
KR102534658B1 (en) | 2023-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4599209A (en) | Method of producing absorbing wound dressing | |
US11590253B2 (en) | Composite materials | |
US5843060A (en) | Non-adherent nasal, sinus and otic packing and method for processing sponge materials in fabrication of packings | |
WO2007103208A3 (en) | Biodegradable foam | |
EP3117842B1 (en) | Tissue dressing material | |
Demitri et al. | Preparation and characterization of cellulose-based foams via microwave curing | |
CN1037523A (en) | Hydrophilic foam compositions | |
KR101865781B1 (en) | Hydrogel comprising oxidized polysaccharide and amine-modified hyaluronic acid for wound dressings and manufacturing method thereof | |
CN102093657B (en) | Cellulose ether modified polyvinyl formal sponge and preparation method thereof | |
CN103937023A (en) | Preparation method of light calcium-alginate-base sponge body functional material | |
CN101927028A (en) | Preparation method of chitosan/ acetalized poval medical dressing | |
CN101181642B (en) | Method for preparing unsymmetrical compound sponge | |
KR102534658B1 (en) | Form for wet dressing and wet dressing used the same that | |
CN103877606A (en) | Absorbable bleeding-stopping compound sponge and preparation method thereof | |
CN103920182A (en) | Biodegradable hemostatic membrane | |
JPH0611810B2 (en) | Porous chitin molding and method for producing the same | |
KR102333779B1 (en) | Protruded polyurethane dressing foam using nitric oxide plasma and its manufacturing method | |
CN110559473A (en) | preparation process of carboxymethyl chitosan hemostatic sponge | |
CA1339074C (en) | Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene | |
DE19712699C2 (en) | Process for the production of wound dressings with wound care active substances | |
JP2004010795A (en) | Foamed material of hydrophilic crosslinked chitosan | |
CN114191601B (en) | Starch gel hemostatic material based on 3D printing technology and preparation method and application thereof | |
KR20020046619A (en) | Multilayer Foam Dressing And Method For Manufacturing Thereof | |
CN106421882B (en) | Absorption styptic sponge | |
CN104324409A (en) | Novel quickly bleed-stooping band-aid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |